These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3549093)

  • 1. Metabolic consequences of bone turnover in Paget's disease of bone.
    Krane SM; Simon LS
    Clin Orthop Relat Res; 1987 Apr; (217):26-36. PubMed ID: 3549093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal metabolism in Paget's disease of bone.
    Krane SM
    Arthritis Rheum; 1980 Oct; 23(10):1087-94. PubMed ID: 7000079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.
    Krane SM; Kantrowitz FG; Byrne M; Pinnell SR; Singer FR
    J Clin Invest; 1977 May; 59(5):819-27. PubMed ID: 404321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease of bone.
    Krane SM
    Clin Orthop Relat Res; 1977; (127):24-36. PubMed ID: 410574
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P; Fledelius C; Gineyts E; Serre CM; Vignot E; Delmas PD
    J Bone Miner Res; 1997 Sep; 12(9):1407-15. PubMed ID: 9286756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
    de la Piedra Gordo C; Torres Jiménez R
    An Med Interna; 1990 Oct; 7(10):534-8. PubMed ID: 2104101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine products of bone breakdown as markers of bone resorption and clinical usefulness of urinary hydroxyproline: an overview.
    Simsek B; Karacaer O; Karaca I
    Chin Med J (Engl); 2004 Feb; 117(2):291-5. PubMed ID: 14975218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disorder of bone quality in Paget's disease].
    Tsurukami H
    Clin Calcium; 2005 Jun; 15(6):1000-6. PubMed ID: 15930714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption.
    Percival RC; Urwin GH; Harris S; Yates AJ; Williams JL; Beneton M; Kanis JA
    Eur J Surg Oncol; 1987 Feb; 13(1):41-9. PubMed ID: 3102281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
    Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
    Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone metabolism.
    Tohmé JF; Seibel MJ; Silverberg SJ; Robins SP; Bilezikian JP
    Z Rheumatol; 1991; 50(3):133-41. PubMed ID: 1927060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers for assessing skeletal growth.
    Robins SP
    Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S199-209. PubMed ID: 8005087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmatic markers of bone metabolism.
    Tamburino G; Fiore CE
    Ann Ital Med Int; 1990; 5(3 Pt 3):296-302. PubMed ID: 2081090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease.
    Delmas PD
    Endocrinol Metab Clin North Am; 1990 Mar; 19(1):1-18. PubMed ID: 2192865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The usefulness of biochemical markers of bone remodelling in the diagnosis and follow-up of Paget's disease of bone, primary hyperparathyroidism, tumoral hypercalcemia and postmenopausal osteoporosis. I. The markers of bone formation].
    de la Piedra Gordo C; Torres Jiménez R
    An Med Interna; 1990 Sep; 7(9):480-6. PubMed ID: 2103291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Paget's disease of bone.
    Langston AL; Ralston SH
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.